BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Next Generation Gene Therapeutics (NGGT) Announces Positive New Data on NGGT002 for the Treatment of Phenylketonuria (PKU)

  November 11, 2024

   · 

  3 min read
• Press Releases

  Koneksa Appoints Eric Luthi as Chief Business Officer

  November 11, 2024

   · 

  2 min read
• Press Releases

  Rubedo Life Sciences Appoints Former Allergan Executive and Biotechnology Veteran Dr. Frederick Beddingfield III as CEO

  November 11, 2024

   · 

  3 min read
• Press Releases

  Cerevance’s CVN293 Demonstrated Positive Phase 1 Results in Healthy Volunteers

  November 11, 2024

   · 

  4 min read
• Press Releases

  First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial

  November 11, 2024

   · 

  10 min read
• Press Releases

  Inozyme Pharma to Present at Upcoming Investor Conferences

  November 11, 2024

   · 

  2 min read
• Press Releases

  Jaguar Health to Hold Investor Webcast Wednesday, November 13th at 8:30 AM Eastern Regarding Q3 2024 Financials & Corporate Updates

  November 11, 2024

   · 

  3 min read
• Press Releases

  Modular Medical Proudly Sponsors the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference

  November 11, 2024

   · 

  2 min read
• Press Releases

  ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)

  November 11, 2024

   · 

  8 min read
• Press Releases

  Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa

  November 11, 2024

   · 

  5 min read